More opposition to IPR changes highlights the tough road ahead for any US patent reform legislation

If patent reform legislation is going to pass in this Congress, consensus will be needed over any reform of the inter partes review process. Since Kyle Bass and Erich Spangenberg started challenging the validity of a series of life sciences patents…

Get unlimited access to all IAM content